Financial Consulate’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.1K Buy
174
+12
+7% +$4.45K 0.01% 295
2026
Q1
$47.5K Buy
162
+6
+4% +$1.97K 0.01% 336
2025
Q4
$54.5K Buy
156
+105
+206% +$35.5K 0.01% 306
2025
Q3
$16.5K Buy
+51
New +$15.9K ﹤0.01% 485

Other funds holding ELV

Financial Consulate's ELV Position: Q2 2026 in Review

Financial Consulate increased its Elevance Health (ELV) stake by 7.4% in Q2 2026, buying an estimated $4.45K and bringing the position to 174 shares worth $67.1K. The position accounts for 0.01% of the portfolio, ranked #295.

Financial Consulate first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Financial Consulate held 174 shares of Elevance Health worth $67.1K as of Q2 2026.
  • Financial Consulate bought 12 Elevance Health shares in Q2 2026, an estimated $4.45K.
  • Elevance Health made up 0.01% of Financial Consulate's portfolio in Q2 2026, its #295 holding.
  • Financial Consulate first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.